TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 4061902

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine, 1.5 mg/kg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 100
Study: 30306439

Group type: EXPERIMENTAL
Intervention: PrEP
Number of subjects: 41
Study: 30317384

Group type: EXPERIMENTAL
Intervention: Wheel-shaped composite cartilage graft (WsCCG)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Temporalis fascia (TF)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Both interventions (WsCCG and TF)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: WsCCG
Number of subjects: 90
Study: 27394404

Group type: EXPERIMENTAL
Intervention: Micafungin
Number of subjects: 250

Group type: COMPARATOR
Intervention: Fluconazole
Number of subjects: 250
Study: 25515105

Group type: EXPERIMENTAL
Intervention: 62-hour total sleep deprivation
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control condition (rested)
Number of subjects: 26
Study: 23904246

Group type: EXPERIMENTAL
Intervention: Vitamin D treatment
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 20884302

Group type: EXPERIMENTAL
Intervention: eFlow rapid nebuliser
Number of subjects: 13

Group type: COMPARATOR
Intervention: LC Plus nebuliser
Number of subjects: 13
Study: 18797057

Group type: EXPERIMENTAL
Intervention: OMP + PUVA
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: OMP + UVB (NB)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: OMP + UVB (BB)
Number of subjects: 86

Group type: COMPARATOR
Intervention: OMP alone
Number of subjects: 86
Study: 17166271

Group type: EXPERIMENTAL
Intervention: Training programme on diagnostic behaviour of clinicians
Number of subjects: 0
Study: 12715373

Group type: COMPARATOR
Intervention: 6-8 cycles of CHOP
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 6 cycles of CHOP and Dexa-BEAM followed by autologous hemopoietic cell transplantation with CBV or BEAM conditioning regimen
Number of subjects: 29
Study: 16464208

Group type: EXPERIMENTAL
Intervention: Becaplermin gel (Regranex) plus good wound care (GWC)
Number of subjects: 314

Group type: COMPARATOR
Intervention: GWC alone
Number of subjects: 314
Study: 9146609

Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 7956719

Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg single dose or 250 mg twice daily)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Midecamycin acetate (600 mg b.i.d.)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 3110105

Group type: EXPERIMENTAL
Intervention: TC3: PCs plus incentives
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TC4: PCs plus incentives and prompts
Number of subjects: 0
Study: 29843203

Group type: EXPERIMENTAL
Intervention: Priming group (Group P, n = 63)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Control group (Group C, n = 63)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Slow injection group (Group S, n = 63)
Number of subjects: 189
Study: 27609624

Group type: EXPERIMENTAL
Intervention: Supportive counseling
Number of subjects: 209

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 209
Study: 24307656

Group type: EXPERIMENTAL
Intervention: High-dose intragraft adenosine infusion (200 μg/min; total dose = 2,000 μg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 22
Study: 23341285

Group type: EXPERIMENTAL
Intervention: Familiar Auditory Sensory Training (FAST) protocol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 20369508

Group type: EXPERIMENTAL
Intervention: ATS mechanical composite graft
Number of subjects: 30

Group type: COMPARATOR
Intervention: SJM mechanical composite graft
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sorin mechanical composite graft
Number of subjects: 30
Study: 18490173

Group type: EXPERIMENTAL
Intervention: Fast track treatment regimen (preoperative fasting 2h, patient controlled epidural analgesia)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conservative treatment regimen (preoperative fasting 6h, patient controlled analgesia)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fast track treatment regimen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conservative treatment regimen
Number of subjects: 0
Study: 16437370

Group type: EXPERIMENTAL
Intervention: VPRG (vagus nerve preserved and reconstruction of gastric funds)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: VPRG
Number of subjects: 68

Group type: COMPARATOR
Intervention: VSNG (vagus nerve severed and no reconstruction of gastric funds)
Number of subjects: 68
Study: 14760891

Group type: EXPERIMENTAL
Intervention: Recombinant viral phenotype method
Number of subjects: 300

Group type: COMPARATOR
Intervention: Virtual phenotype (genotyping interpretation system)
Number of subjects: 300
Study: 10382694

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy
Number of subjects: 990

Group type: COMPARATOR
Intervention: Medical treatment only
Number of subjects: 990
Study: 8967601

Group type: EXPERIMENTAL
Intervention: 3.75 mg midazolam p.o. (Dormicum)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo orally 30 min before RBA
Number of subjects: 47
Study: 1319542

Group type: EXPERIMENTAL
Intervention: 0.5 micrograms/kg hANP-(95-126) (Urodilatin)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 2.0 micrograms/kg hANP-(95-126) (Urodilatin)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: hANP
Number of subjects: 32
Study: 6379784

Group type: EXPERIMENTAL
Intervention: Non-specific immunotherapy (aqueous suspension of heat killed mycobacterium smegmatis, administered subcutaneously once a month)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Control group (no other treatment following excision)
Number of subjects: 219
Study: 31477562

Group type: EXPERIMENTAL
Intervention: Modified Mediterranean-ketogenic diet (MMKD)
Number of subjects: 17

Group type: COMPARATOR
Intervention: American Heart Association Diet (AHAD)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: MMKD
Number of subjects: 17

Group type: COMPARATOR
Intervention: AHAD
Number of subjects: 17
Study: 29965991

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided peripheral nerve block (PNB) with 10 mL prilocaine 1% and 10 mL ropivacaine 0.2%
Number of subjects: 30

Group type: COMPARATOR
Intervention: Analgosedation (AS) with midazolam combined with s-ketamine or fentanyl
Number of subjects: 30
Study: 26902832

Group type: EXPERIMENTAL
Intervention: Yukmijihwang-tang (YMJ) administered at 3g, three times per day for 8 weeks
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo administered at 3g, three times per day for 8 weeks
Number of subjects: 96
Study: 25158865

Group type: EXPERIMENTAL
Intervention: DPP4 inhibitor (sitagliptin 200 mg by mouth)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: GLP-1 infusion
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: BNP infusion
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: GLP-1 and BNP
Number of subjects: 17
Study: 21574670

Group type: COMPARATOR
Intervention: Parental monitoring
Number of subjects: 256

Group type: COMPARATOR
Intervention: Prematriculation social modeling among peers
Number of subjects: 256

Group type: COMPARATOR
Intervention: Prematriculation descriptive norms
Number of subjects: 256

Group type: COMPARATOR
Intervention: Parental drinking permissiveness
Number of subjects: 256

Group type: COMPARATOR
Intervention: Social modeling among peers
Number of subjects: 256
Study: 20634635

Group type: EXPERIMENTAL
Intervention: Abdominal breathing (modified Mason's breathing technique), 3 times a day for 3 days
Number of subjects: 60
Study: 17216336

Group type: EXPERIMENTAL
Intervention: 100 mg CS‐706 once daily
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 200 mg CS‐706 once daily
Number of subjects: 160

Group type: COMPARATOR
Intervention: 500 mg naproxen twice daily
Number of subjects: 160
Study: 16311656

Group type: EXPERIMENTAL
Intervention: Type 1 diabetic patients
Number of subjects: 27

Group type: COMPARATOR
Intervention: Matched controls
Number of subjects: 27
Study: 11952197

Group type: EXPERIMENTAL
Intervention: Same context as extinction
Number of subjects: 78

Group type: COMPARATOR
Intervention: Different context
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Different context with E-cue
Number of subjects: 78
Study: 9854762

Group type: EXPERIMENTAL
Intervention: Informative approach with clinical examination and education in a 'mini back school'.
Number of subjects: 489

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 489
Study: 7793169

Group type: EXPERIMENTAL
Intervention: Gemeprost (1 mg) as a vaginal suppository in 12 hour intervals
Number of subjects: 68

Group type: COMPARATOR
Intervention: Dinoprost (500 micrograms) in a tylose-gel in 6-8 hour intervals
Number of subjects: 68
Study: 2193840

Group type: EXPERIMENTAL
Intervention: 20 mg frusemide/2.5 mg amiloride
Number of subjects: 71

Group type: COMPARATOR
Intervention: 0.25 mg cyclopenthiazide/8.1 mmol sustained release potassium
Number of subjects: 71
Study: 842487

Group type: EXPERIMENTAL
Intervention: Urea supplementation (4 g of nitrogen)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Opaque-2 corn (6 g of nitrogen)
Number of subjects: 7
Study: 31332449

Group type: EXPERIMENTAL
Intervention: Anticipatory method
Number of subjects: 237

Group type: COMPARATOR
Intervention: ERC algorithm
Number of subjects: 237
Study: 29199342

Group type: EXPERIMENTAL
Intervention: Group A (receiving interventions)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Group B (no interventions)
Number of subjects: 153
Study: 25743742

Group type: EXPERIMENTAL
Intervention: Palliative Care Professional education program (5 sessions, 16 content items for 2 weeks)
Number of subjects: 86
Study: 23415616

Group type: EXPERIMENTAL
Intervention: Incentive-based physical activity intervention
Number of subjects: 285

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 285
Study: 21270380

Group type: EXPERIMENTAL
Intervention: Vitamin D(3) supplementation 5 μg/d
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Vitamin D(3) supplementation 10 μg/d
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Vitamin D(3) supplementation 6.3 μg/d
Number of subjects: 144

Group type: COMPARATOR
Intervention: Vitamin D(3) supplementation 0 μg/d (placebo)
Number of subjects: 144
Study: 19011511

Group type: EXPERIMENTAL
Intervention: Vincristine sulfate liposome infusion (VSLI) at 2.0 mg/m infused over 1 hour every 2 weeks (one cycle)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Vincristine sulfate liposome infusion (VSLI)
Number of subjects: 27
Study: 16414124

Group type: EXPERIMENTAL
Intervention: Bupivacaine (n=16)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Ropivacaine (n=15)
Number of subjects: 46

Group type: COMPARATOR
Intervention: 9% NaCl (saline) (control group, n=15)
Number of subjects: 46
Study: 12923641

Group type: EXPERIMENTAL
Intervention: Intermittent Exercise (IEx) at 50% and 70% VO2peak
Number of subjects: 9

Group type: COMPARATOR
Intervention: Continuous Exercise (CEx) at 70% VO2peak
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Intermittent Exercise (IEx) 60sE:60sR at 70% VO2peak
Number of subjects: 9

Group type: COMPARATOR
Intervention: Continuous Exercise (CEx) and Intermittent Exercise (IEx) at 50% VO2peak
Number of subjects: 9
Study: 10883560

Group type: EXPERIMENTAL
Intervention: Group cognitive-behavioral therapy
Number of subjects: 143
Study: 9020419

Group type: EXPERIMENTAL
Intervention: 0.5% morphine HCl nasal challenge
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Workplace trial with bronchodilator and placebo
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Nasal and bronchial challenge with 0.5% morphine HCl
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 5
Study: 1411923

Group type: EXPERIMENTAL
Intervention: Cis platinum (Cis PII) 100 mg/m2 i.v. followed by 6 Gy irradiation in two fractions on days 3 and 5, five cycles at 21 days interval.
Number of subjects: 19

Group type: COMPARATOR
Intervention: Three fractions per day radiotherapy regimen (3 FRT) in split-course (two series of 22.50 Gy in 15 fractions, five days separated by two weeks rest).
Number of subjects: 19
Study: 3871251

Group type: EXPERIMENTAL
Intervention: Triple sulfonamide combined with either phenoxymethyl penicillin or benzathine and procaine penicillin G (IM)
Number of subjects: 948

Group type: EXPERIMENTAL
Intervention: Phenoxymethyl penicillin and cyclacillin alone
Number of subjects: 948

Group type: EXPERIMENTAL
Intervention: Cefaclor and trimethoprim-sulfamethoxazole
Number of subjects: 948
Study: 31571070

Group type: EXPERIMENTAL
Intervention: Hydrophilic contact lenses (Omafilcon A)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Hydrophobic contact lens (Hexafocon A)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (no contact lens)
Number of subjects: 18
Study: 30860055

Group type: EXPERIMENTAL
Intervention: Aspiration first pass
Number of subjects: 270

Group type: COMPARATOR
Intervention: Stent retriever first line
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 270
Study: 29228950

Group type: EXPERIMENTAL
Intervention: Indacaterol/glycopyrronium (IND/GLY)
Number of subjects: 0

Group type: COMPARATOR
Intervention: salmeterol/fluticasone (SFC)
Number of subjects: 0
Study: 25521661

Group type: EXPERIMENTAL
Intervention: Project Connect Online (PCO) intervention, a 3-hour workshop for creation of personal websites with a blog function.
Number of subjects: 88

Group type: COMPARATOR
Intervention: Waiting-list control group (not explicitly detailed in outcomes).
Number of subjects: 88
Study: 24708349

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE) therapy
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 200
Study: 22466866

Group type: EXPERIMENTAL
Intervention: Podcasted exemplars
Number of subjects: 0
Study: 20953168

Group type: EXPERIMENTAL
Intervention: 1.8 mL lidocaine plus dummy lingual injection (LB)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 0.9 mL lidocaine (LBL)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 1.8 mL articaine plus dummy lingual injection (AB)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 0.9 mL articaine (ABL)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 4% articaine
Number of subjects: 31

Group type: COMPARATOR
Intervention: 2% lidocaine
Number of subjects: 31
Study: 17437743

Group type: EXPERIMENTAL
Intervention: Anemia (defined as baseline hematocrit <36%)
Number of subjects: 6360

Group type: EXPERIMENTAL
Intervention: Anemia in subjects with CKD (baseline GFR ≤60 ml/min/1.73 m²)
Number of subjects: 6360

Group type: EXPERIMENTAL
Intervention: Anemia in subjects without CKD
Number of subjects: 6360
Study: 16353881

Group type: EXPERIMENTAL
Intervention: Prednisolone acetate 1%
Number of subjects: 68

Group type: COMPARATOR
Intervention: Rimexolone 1%
Number of subjects: 68
Study: 12225796

Group type: EXPERIMENTAL
Intervention: PEG‐rHuMGDF (various doses)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: PEG‐rHuMGDF (minimally effective dose)
Number of subjects: 139
Study: 12179676

Group type: EXPERIMENTAL
Intervention: Oxytocin administered at the end of the second stage of labor
Number of subjects: 130
Study: 7784413

Group type: EXPERIMENTAL
Intervention: Cabergoline (CAB 0.5‐1 mg twice weekly)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Bromocriptine (BRC 2.5‐5 mg twice daily)
Number of subjects: 120
Study: 2353171

Group type: EXPERIMENTAL
Intervention: Delayed-release, enteric-coated tablet of mesalazine (Claversal)
Number of subjects: 13
Study: 383174

Group type: EXPERIMENTAL
Intervention: Antifibrinolytic substance (AMCHA)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Bothrops Jararaca venom extract
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 29618272

Group type: EXPERIMENTAL
Intervention: Fortified pasteurized donor human milk (PDHM)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Unfortified pasteurized donor human milk (PDHM)
Number of subjects: 80
Study: 27052039

Group type: EXPERIMENTAL
Intervention: Endovenous cyanoacrylate (Sapheon Venaseal Closure System)
Number of subjects: 29
Study: 25906561

Group type: EXPERIMENTAL
Intervention: Acupuncture (resuscitation and tranquilization technique) applied to specific acupuncture points (Shenting, Shuigou, Sishencong, Baihui, Feng-chi) once daily, 6 times a week for 8 weeks.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Deanxit (oral administration, 1 tablet in the morning and lunchtime each day for 8 weeks).
Number of subjects: 40
Study: 23722881

Group type: EXPERIMENTAL
Intervention: Dalteparin
Number of subjects: 3746

Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH)
Number of subjects: 3746

Group type: COMPARATOR
Intervention: UFH
Number of subjects: 3746
Study: 22192566

Group type: EXPERIMENTAL
Intervention: Pragmatic rehabilitation
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Supportive listening
Number of subjects: 46
Study: 18954875

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 1398

Group type: COMPARATOR
Intervention: Pooled comparators (citalopram, duloxetine, paroxetine)
Number of subjects: 1398
Study: 17905358

Group type: EXPERIMENTAL
Intervention: Intentionally treated chocolate (three different techniques)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Intentionally treated chocolate (for individuals consuming less than 3.2 ounces of chocolate per week)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Intentionally treated chocolate (general mood factors)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Untreated chocolate (placebo control)
Number of subjects: 62
Study: 16304902

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: MTOPS study
Number of subjects: 5
Study: 12166883

Group type: EXPERIMENTAL
Intervention: Exercise consultation
Number of subjects: 370

Group type: COMPARATOR
Intervention: Fitness assessment
Number of subjects: 370
Study: 10628768

Group type: EXPERIMENTAL
Intervention: CMV disease with acute rejection
Number of subjects: 1339

Group type: EXPERIMENTAL
Intervention: Acute rejection
Number of subjects: 1339

Group type: EXPERIMENTAL
Intervention: Older donor age
Number of subjects: 1339

Group type: EXPERIMENTAL
Intervention: CMV disease
Number of subjects: 1339

Group type: EXPERIMENTAL
Intervention: Acute rejection with CMV disease
Number of subjects: 1339

Group type: COMPARATOR
Intervention: No acute rejection with CMV disease
Number of subjects: 1339
Study: 7883938

Group type: EXPERIMENTAL
Intervention: Capsulorrhaphy
Number of subjects: 39

Group type: COMPARATOR
Intervention: Capsulectomy
Number of subjects: 39
Study: 1697916

Group type: EXPERIMENTAL
Intervention: Internal urethrotomy of the prostatic urethra
Number of subjects: 49

Group type: COMPARATOR
Intervention: Transurethral resection of the prostate
Number of subjects: 49
Study: 380610

Group type: EXPERIMENTAL
Intervention: Meptazinol 100 mg/70 kg
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Morphine 10 mg/70 kg
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Pentazocine 60 mg/70 kg
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 30961631

Group type: EXPERIMENTAL
Intervention: Stapleless bypass surgery (LOAGB-OSPAN)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard gastric bypass surgery (LMGB-OAGB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-surgical weight loss therapy (hypocaloric diet -500 kcal/day)
Number of subjects: 0
Study: 29389246

Group type: EXPERIMENTAL
Intervention: Intravenous acetazolamide (Az; 10 mg/kg) plus intravenous dobutamine (Dob) infusion (2-5 μg·kg-1·min-1)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Oral indomethacin (Indo; 100 mg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 27113231

Group type: EXPERIMENTAL
Intervention: Internet-delivered exposure-based cognitive behaviour therapy (ICBT) for 12 weeks
Number of subjects: 158

Group type: COMPARATOR
Intervention: Internet-delivered behavioural stress management (IBSM) for 12 weeks
Number of subjects: 158
Study: 24662777

Group type: EXPERIMENTAL
Intervention: Ezetimibe (10 mg/day, n = 24)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Simvastatin (40 mg/day, n = 24)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Combination of ezetimibe and simvastatin (n = 24)
Number of subjects: 72
Study: 22510027

Group type: EXPERIMENTAL
Intervention: GerdQ-based algorithm (NSP)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Endoscopy-based approach (OCP)
Number of subjects: 280
Study: 20803425

Group type: EXPERIMENTAL
Intervention: 1 g/day fish oil capsule (with 180 mg EPA and 120 mg DHA, totaling 300 mg n-3 fatty acids)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study: 18070852

Group type: EXPERIMENTAL
Intervention: Active 10 Hz suprathreshold rTMS to the left dorsolateral prefrontal cortex
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 10
Study: 15992878

Group type: EXPERIMENTAL
Intervention: Portable, camera-less laparoscopic trainer (group 1)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard video laparoscopic trainer (group 2)
Number of subjects: 22
Study: 12610804

Group type: EXPERIMENTAL
Intervention: Intermittent cyclical etidronate therapy (ICET)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Non-ICET group
Number of subjects: 63
Study: 10333100

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with three different treatment parameters
Number of subjects: 9

Group type: COMPARATOR
Intervention: Fluorescein angiography (FA) examinations
Number of subjects: 9
Study: 7734269

Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: 1.0% ropivacaine
Number of subjects: 126

Group type: COMPARATOR
Intervention: 0.5% bupivacaine
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Higher concentrations of ropivacaine
Number of subjects: 126
Study: 2340607

Group type: EXPERIMENTAL
Intervention: Tetanic nerve stimulation (50 Hz, 5 sec)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Clinical tactile assessment of the response to tetanic stimulation
Number of subjects: 44
Study: 373071

Group type: EXPERIMENTAL
Intervention: Cimetidine, 400 mg twice daily
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo (inactive tablets)
Number of subjects: 19